Oral chemotherapies
5.2 | 1.1
New targeted agents have the same frequency and severity of toxicities as traditional cytotoxic agents, with the difference being the nature of the toxic effects. Thus, the classical chemotherapy toxicities (vomiting, myelosuppression, mucositis, nausea, and alopecia) have been generally replaced by endocrine, dermatologic, vascular, coagulation, immunologic, ocular, and pulmonary toxicities. These toxicities need to be recognized, prevented, and optimally managed.
AKPO was created by Mr. Benoît Brouard PharmD and Mrs. Pascale Bardo PharmD under the medico-scientific supervision of Mr. Stéphane Vignot MD Oncologist and Head of Oncology and Service hematology to Chârtres Hospitals.
AKPO provides an overview of these toxicities, associated with new targeted agents, and relevant informations for the management of patients.
These informations are based on current recommendations of international scientific publications.
The interface of the application is designed to facilitate access to content. It is divided into four tabs:
• Search
• Adverse events
• Oral targeted therapies
• Informations
The first three tabs will be used to access to the data in the application.
The
